Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

por Halpin, David M G
Publicado 2023

Tiotropium in asthma: what is the evidence and how does it fit in?

por Halpin, David M. G.
Publicado 2016

The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease

por Halpin, David M. G.
Publicado 2018

Precision medicine in chronic obstructive pulmonary disease

por Halpin, David M.G.
Publicado 2022

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?

por Singh, Dave, Halpin, David M G
Publicado 2020

Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease

por Mahler, Donald A., Halpin, David M. G.
Publicado 2023

Defining Disease Modification in Chronic Obstructive Pulmonary Disease

por Halpin, David M.G., Tashkin, Donald P.
Publicado 2009

Inhalation Devices

por Moroni-Zentgraf, Petra, Usmani, Omar S., Halpin, David M. G.
Publicado 2018

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

por Halpin, David M.G., Singh, Dave, Hadfield, Ruth M.
Publicado 2020

Impact of comorbid conditions on asthmatic adults and children

por Kaplan, Alan, Szefler, Stanley J., Halpin, David M. G.
Publicado 2020

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022

por Halpin, David M. G., Vogelmeier, Claus F., Agusti, Alvar
Publicado 2022

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado 2021

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado 2021

Investigating Women’s Experiences of Asthma Care in Pregnancy: A Qualitative Study

por Chamberlain, Chervonne, Williamson, Graham R, Knight, Beatrice, Daly, Mark, Halpin, David M.G
Publicado 2014

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

por Halpin, David M G, Faner, Rosa, Sibila, Oriol, Badia, Joan Ramon, Agusti, Alvar
Publicado 2020

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

por Halpin, David M. G., Kerkhof, Marjan, Soriano, Joan B., Mikkelsen, Helga, Price, David B.
Publicado 2016

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial

por Halpin, David M. G., Decramer, Marc, Celli, Bartolome, Kesten, Steven, Leimer, Inge, Tashkin, Donald P.
Publicado 2011

Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019

por Halpin, David M.G., de Jong, Hilda J.I., Carter, Victoria, Skinner, Derek, Price, David
Publicado 2019

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

por Halpin, David M.G., Vogelmeier, Claus F., Mezzi, Karen, Gupta, Pritam, Kostikas, Konstantinos, Wedzicha, Jadwiga A.
Publicado 2021

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

por Tashkin, Donald P., Miravitlles, Marc, Celli, Bartolomé R., Metzdorf, Norbert, Mueller, Achim, Halpin, David M. G., Anzueto, Antonio
Publicado 2018